Trastuzumab Recruiting Phase 1 / 2 Trials for Cancer, Breast Treatment

Indications	Status	Purpose	Phase
DBCOND0054116 (Cancer, Breast)	Recruiting	Treatment	1 / 2

clinicaltrials.gov Identifier	Title	Drugs
NCT03135171	Trastuzumab and Pertuzumab in Combination With Tocilizumab in Subjects With Metastatic HER2 Positive Breast Cancer Resistant to Trastuzumab	Pertuzumab (DB06366) Tocilizumab (DB06273) Trastuzumab (DB00072)
NCT01969643	A Safety Study of SGN-LIV1A in Breast Cancer Patients	Trastuzumab (DB00072)
NCT02562378	T-DM1 and Non-pegylated Liposomal Doxorubicin in HER2-positive Metastatic Breast Cancer	Trastuzumab (DB00072) Trastuzumab emtansine (DB05773)